AV

Anteris Technologies Global Corp.

AVR · Nasdaq

Anteris Technologies Global Corp. (AVR) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Anteris Technologies Global Corp. in 2026. The next earnings report is expected on November 18, 2026.

Earnings calendar

Next earnings date

18 Nov 2026

In 89 days

EPS estimate

-0.25

Revenue estimate

3.0M

Past earnings

10 Aug 2026
EPS actual
-0.20 (+2.6%)
estimate -0.21
Revenue actual
1.1M (-26.7%)
estimate 1.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
-0.28 (-3.4%)
estimate -0.27
Revenue actual
494.0K (-35.6%)
estimate 766.7K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
26 Feb 2026
EPS actual
-0.74 (-47.0%)
estimate -0.50
Revenue actual
303.0K (+51.5%)
estimate 200.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Anteris Technologies Global Corp. beat consensus estimates in its latest earnings report, with EPS of $-0.2019 versus an estimate of $-0.2073, while revenue of $1.1 million fell 26.7% short of expectations. In the prior quarter both EPS and revenue were below expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.

Sector
Healthcare
Industry
Medical devices
Country
Australia
Exchange
Nasdaq
CEO
Wayne Geoffrey Paterson
Employees
136
IPO date
13 Dec 2024
ISIN
US03675P1021
Website
anteristech.com

Frequently asked questions

When does Anteris Technologies Global Corp. (AVR) next report earnings?

Anteris Technologies Global Corp. (AVR) is scheduled to report earnings on November 18, 2026.

What was Anteris Technologies Global Corp.'s most recent earnings date?

Anteris Technologies Global Corp. (AVR) last reported earnings on August 10, 2026.

Where is Anteris Technologies Global Corp. stock listed?

Anteris Technologies Global Corp. (AVR) is listed on Nasdaq.